These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34662566)

  • 21. CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo.
    Dan H; Lei X; Huang X; Ma N; Xing Y; Shen Y
    Microvasc Res; 2021 Jul; 136():104146. PubMed ID: 33610563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An arylidene-thiazolidinedione derivative, GPU-4, without PPARγ activation, reduces retinal neovascularization.
    Nakamura S; Hayashi K; Takizawa H; Murase T; Tsuruma K; Shimazawa M; Kakuta H; Nagasawa H; Hara H
    Curr Neurovasc Res; 2011 Feb; 8(1):25-34. PubMed ID: 21208163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC.
    Hui X; Han Y; Liang S; Liu Z; Liu J; Hong L; Zhao L; He L; Cao S; Chen B; Yan K; Jin B; Chai N; Wang J; Wu K; Fan D
    J Control Release; 2008 Oct; 131(2):86-93. PubMed ID: 18700158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant alpha2(IV)NC1 domain of type IV collagen is an effective regulator of retinal capillary endothelial cell proliferation and inhibits pre-retinal neovascularisation.
    Coleman G; Gardiner TA; Boutaud A; Stitt AW
    Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):581-7. PubMed ID: 16915401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
    Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
    Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Yin J; Xin B; Hui X; Chai N; Yao L; Hu H; Xu B; Ma W; Zhang M; Wang J; Nie Y; Zhou G; Wang G; Chen L; Lu H; Wu K
    Eur J Pharm Biopharm; 2020 Sep; 154():144-152. PubMed ID: 32682942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.
    Chikaraishi Y; Shimazawa M; Yokota K; Yoshino K; Hara H
    Curr Neurovasc Res; 2009 Aug; 6(3):140-7. PubMed ID: 19534723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N; Xu H; Yu N; Wu Y; Yu L
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs.
    Ding X; Gu R; Zhang M; Ren H; Shu Q; Xu G; Wu H
    BMC Ophthalmol; 2018 Sep; 18(1):249. PubMed ID: 30223824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).
    Zhao H; Jin H; Li Q; Gu Q; Zheng Z; Wu H; Ye S; Sun X; Xu X; Ho PC
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5384-95. PubMed ID: 19515999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.
    Cano Mdel V; Karagiannis ED; Soliman M; Bakir B; Zhuang W; Popel AS; Gehlbach PL
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3840-5. PubMed ID: 19279315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Small Peptide H-KI20 Inhibits Retinal Neovascularization Through the JNK/ATF2 Signaling Pathway.
    Wang R; Xu Y; Niu C; Gao X; Xu X
    Invest Ophthalmol Vis Sci; 2021 Jan; 62(1):16. PubMed ID: 33439229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of TRPV1 and TRPV4 Channels in Retinal Angiogenesis.
    O'Leary C; McGahon MK; Ashraf S; McNaughten J; Friedel T; Cincolà P; Barabas P; Fernandez JA; Stitt AW; McGeown JG; Curtis TM
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3297-3309. PubMed ID: 31369032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
    Zheng Y; Gu Q; Xu X
    Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism.
    Valentine A; O'Rourke M; Yakkundi A; Worthington J; Hookham M; Bicknell R; McCarthy HO; McClelland K; McCallum L; Dyer H; McKeen H; Waugh DJ; Roberts J; McGregor J; Cotton G; James I; Harrison T; Hirst DG; Robson T
    Clin Cancer Res; 2011 Mar; 17(5):1044-56. PubMed ID: 21364036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
    Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy.
    Zhang J; Zhao R; Chen J; Jin J; Yu Y; Tian Y; Li W; Wang W; Zhou H; Bo Su S
    Sci Rep; 2017 Jun; 7(1):2756. PubMed ID: 28584235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenic effect of KH902 on retinal neovascularization.
    Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.
    Barnett JM; Suarez S; McCollum GW; Penn JS
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6490-8. PubMed ID: 25159209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.